Peptides

SEMAX

Semax is a synthetic nootropic and neuroprotective peptide derived from the ACTH hormone fragment. It is widely researched for its potential to support focus, memory, mental clarity, neuroprotection, cognitive performance, and BDNF activity without significant hormonal effects. Commonly studied in cognitive enhancement and neurological recovery research.

  • ✔ High purity research-grade compound
  • ✔ Laboratory tested quality assurance
  • ✔ Secure packaging & global standards
Contact for Inquiry

Product Description

Semax is a synthetic heptapeptide developed from the adrenocorticotropic hormone (ACTH) fragment 4-10, with the amino acid sequence Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP). Originally developed by Russian researchers, Semax has been extensively studied for its nootropic, neuroprotective, and neuroregulatory properties.

Unlike full ACTH, Semax was specifically engineered to retain cognitive and neuroprotective benefits while minimizing endocrine and cortisol-stimulating effects. This unique mechanism has made it one of the most recognized research peptides in the cognitive enhancement and neuroplasticity category.

Research suggests that Semax may influence several neurological pathways, including:

  • Brain-Derived Neurotrophic Factor (BDNF) activity
  • Nerve Growth Factor (NGF) signaling
  • Dopamine and serotonin modulation
  • Neuroplasticity and synaptic function
  • Anti-inflammatory and neuroprotective pathways

These mechanisms have led to extensive research involving memory, focus, learning capacity, mental clarity, mood regulation, and recovery from neurological stress.

Semax has also been researched in areas involving:

  • Cognitive enhancement and focus
  • Mental performance optimization
  • Neuroprotection research
  • Memory and learning support
  • Brain recovery studies
  • Stress resilience and mood support
  • Attention and concentration research

One of the major reasons for Semax’s popularity within nootropic research is that it is not considered a traditional stimulant. Instead of aggressively increasing neurotransmitter release, Semax is believed to support long-term neuroplasticity and cognitive regulation pathways.

Semax is commonly researched in intranasal form due to its rapid CNS accessibility and bioavailability. It has been approved and prescribed in Russia for neurological and cognitive applications, although outside Russia it remains primarily a research compound.

Key Features

  • Advanced nootropic research peptide
  • Studied for focus, memory, and cognition
  • Supports BDNF and NGF activity research
  • Neuroprotective and neuroplasticity support
  • Non-stimulant cognitive enhancement peptide
  • Researched for neurological recovery applications

Research Use Notice

This product is intended strictly for laboratory and research purposes only. It is not approved for human consumption or medical use in many jurisdictions.